Stock Analysis
Avantor (NYSE:AVTR) Second Quarter 2024 Results
Key Financial Results
- Revenue: US$1.70b (down 2.4% from 2Q 2023).
- Net income: US$92.9m (up from US$7.30m loss in 2Q 2023).
- Profit margin: 5.5% (up from net loss in 2Q 2023). The move to profitability was driven by lower expenses.
- EPS: US$0.14 (up from US$0.011 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Avantor EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%.
Looking ahead, revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 6.6% growth forecast for the Life Sciences industry in the US.
Performance of the American Life Sciences industry.
The company's shares are up 23% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Avantor, and understanding it should be part of your investment process.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About NYSE:AVTR
Avantor
Engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa.
Fair value with moderate growth potential.
